APA (7th ed.) Citation

Ramirez, A. D. E., C. Helmijr, J., Lurkin, I., Look, M., Ruigrok-Ritstier, K., Simon, I., . . . Jansen, M. P. H. M. (2012). Hotspot mutations in PIK3CA are predictive for treatment outcome on aromatase inhibitors but not for tamoxifen. Cancer Research, 72(24a), 871. https://doi.org/10.1158/0008-5472.SABCS12-P3-06-01

Chicago Style (17th ed.) Citation

Ramirez, Ardila D. E., et al. "Hotspot Mutations in PIK3CA Are Predictive for Treatment Outcome on Aromatase Inhibitors but Not for Tamoxifen." Cancer Research 72, no. 24a (2012): 871. https://doi.org/10.1158/0008-5472.SABCS12-P3-06-01.

MLA (9th ed.) Citation

Ramirez, Ardila D. E., et al. "Hotspot Mutations in PIK3CA Are Predictive for Treatment Outcome on Aromatase Inhibitors but Not for Tamoxifen." Cancer Research, vol. 72, no. 24a, 2012, p. 871, https://doi.org/10.1158/0008-5472.SABCS12-P3-06-01.